Lv02
0 积分 2024-10-18 加入
Post-marketing safety surveillance of erenumab: new insight from Eudravigilance
4小时前
待确认
Postmarketing Safety Surveillance
1天前
已完结
Post-marketing safety surveillance of erenumab: new insight from Eudravigilance
8天前
已完结
Bulevirtide and emerging drugs for the treatment of hepatitis D
9天前
已完结
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System
1个月前
已完结
Cardiovascular toxicities of hypoxia-inducible factor prolyl hydroxylase inhibitors: a disproportionality analysis based on JADER database
2个月前
已完结
A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study
6个月前
已完结
皖公网安备34019202002308
